JNK1 is thought to function as a tumor promoter in lung cancer and primary hepatocellular carcinoma [6, 7], and JNK2 promotes carcinogenesis in skin cancer and myeloma [8, 9]. The gene discussed is MAPK9; the disease is plasma cell myeloma.